Literature DB >> 1899120

High affinity [3H]glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristics.

J A Miller1, N L Velayo, R C Dage, D Rampe.   

Abstract

We examined the binding of the antidiabetic sulfonylurea [3H] glibenclamide to rat brain and heart membranes. High affinity binding was observed in adult rat forebrain (Kd = 137.3 pM, maximal binding site density = 91.8 fmol/mg of protein) and ventricle (Kd = 77.1 pM, maximal binding site density = 65.1 fmol/mg of protein). Binding site density increased approximately 250% in forebrain membranes during postnatal development but was constant in ventricular membranes. Quantitative autoradiography was used to examine the regional distribution of [3H] glibenclamide binding sites in sections from rat brain, spinal cord and heart. The greatest density of binding in adult brain was found in the substantia nigra and globus pallidus, whereas the other areas displayed heterogenous binding. In agreement with the membrane binding studies, 1-day-old rat brain had significantly fewer [3H]glibenclamide binding sites than adult brain. Additionally, the pattern of distribution of these sites was qualitatively different from that of the adult. In adult rat spinal cord, moderate binding densities were observed in spinal cord gray and displayed a rostral to caudal gradient. In adult rat heart, moderate binding densities were observed and the sites were distributed homogeneously. In conclusion, significant development of [3H]glibenclamide binding sites was seen in the brain but not the heart during postnatal maturation. Furthermore, a heterogeneous distribution of binding sites was observed in both the brain and spinal cord of adult rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899120

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Identification of an ATP-sensitive K+ channel in rat cultured cortical neurons.

Authors:  T Ohno-Shosaku; C Yamamoto
Journal:  Pflugers Arch       Date:  1992-12       Impact factor: 3.657

2.  MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.

Authors:  J A Miller; M W Dudley; J H Kehne; S M Sorensen; J M Kane
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

3.  Wortmannin, an inhibitor of phosphatidylinositol kinases, blocks the MgATP-dependent recovery of Kir6.2/SUR2A channels.

Authors:  L H Xie; M Takano; M Kakei; M Okamura; A Noma
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

4.  Effects of nicorandil on the recovery of reflex potentials after spinal cord ischaemia in cats.

Authors:  T Suzuki; T Sekikawa; T Nemoto; H Moriya; H Nakaya
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.

Authors:  A J Sellers; P R Boden; M L Ashford
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

6.  Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form.

Authors:  A Virsolvy-Vergine; G Salazar; R Sillard; L Denoroy; V Mutt; D Bataille
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.